Immune Checkpoint Inhibitor/Chemotherapy Combinations for Metastatic Triple-Negative Breast Cancer: Emerging Clinical Data and Managed Care Considerations
This activity will determine the biological rationale for available and emerging treatment strategies involving immune checkpoint inhibitor (ICI)/chemotherapy combinations for the treatment of metastatic triple-negative breast cancer (mTNBC)
New and Emerging Management Strategies for Acute Graft-Versus-Host Disease in Hematopoietic Stem Cell Transplant
This activity will review clinical data for new and emerging strategies in aGVHD prevention and treatment, the role of biomarkers, and the role of the pharmacist in patient care.
Continuing the Conversation | Anticoagulation in Arterial Disease: Exploring the Evidence
This activity will provide an overview of current guidelines for secondary prevention in CAD/PAD including the role of anticoagulation in risk reduction.
CAD/PAD: Examining the Burden
This activity will provide pharmacists with an overview of atherosclerotic disease, including risk factors and challenges in secondary prevention.